Skip to content
Search

Latest Stories

Amgen sues Novartis in US court to block generic osteoporosis, bone cancer drugs

Pb Staff writer
By Pb Staff writerMay 03, 2023
Pb Staff writer
See Full Bio

Amgen Inc sued Novartis AG's Sandoz in a federal court in the United States on Monday (May 1), accusing Sandoz's proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents.

Amgen asked the New Jersey court to block Sandoz's biosimilars of the drugs until its patents expire. One of the patents named in the complaint does not expire until 2037.

Sandoz declined to comment on the lawsuit on Tuesday. Novartis, which is also named in the complaint, is preparing to spin Sandoz off into a standalone company later this year.

Amgen's Prolia is used to treat osteoporosis. Xgeva, with the same active ingredient denosumab, treats bone cancer and prevents fractures in bone-cancer patients.

Amgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.

proliaamgensandozxgevanovartis

Related News

future of community pharmacy

CPE hosts ministers to discuss the future of community pharmacy

national prescribing service for pharmacists
News

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

Wes Streeting NHS reforms

Breaking news: “We are about to conclude community pharmacy contract,” says Streeting

Keir Starmer scraps NHS England to bring it back under 'democratic control'
News

Keir Starmer scraps NHS England to bring it back under 'democratic control'

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
TV star Kym Marsh joins NHS ‘No Smoking Day’ campaign

Kym Marsh speaking about her journey to quitting smoking as part of the NHS No Smoking Day campaign.

Photo credit: Better Health

TV star Kym Marsh joins NHS ‘No Smoking Day’ campaign

TV star, singer, and actor Kym Marsh has teamed up with the NHS for a powerful new campaign, urging the UK’s six million smokers to make a quit attempt this No Smoking Day (12 March).

In a touching new film, the former Coronation Street star opens up about her journey to breaking free from smoking—an addiction that once dictated her daily routine.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc